PetMed Express (PETS) Q4 FY26 earnings call

PetMed Express reported a challenging Q4 FY26 with net sales down 15.6% year-over-year, contributing to a full-year decline of 21.1%. Despite this, the company achieved its first sequential quarterly sales increase since FY24 and made significant operational and cultural improvements, including cost reductions and technology modernizations. The Board also evaluated and rejected two unsolicited acquisition proposals, opting to continue as an independent entity while remaining open to future interest.